glp-1 obesity drugs updates today drugs, originally developed to treat diabetes and now widely used for obesity, are reshaping healthcare in the US. ⁣, ⁣, As research uncovers potential benefits beyond weight loss, experts are Weight loss with GLP-1 medicines

Reveal smoother, brighter, and more radiant-looking skin with First Lady Glutawhite Gold Egyptian Lotion

These medications (including semaglutide, dulaglutide, and liraglutide) are typically considered when: Metformin and other oral medications have not achieved adequate glycaemic control The patient has a BMI 35 kg/m (or lower thresholds, typically by around 2.5 kg/m, for people of certain ethnic backgrounds including South Asian) Weight loss would benefit other obesity-related comorbidities Insulin therapy is being considered but would have significant occupational implications or weight gain is a concern Continuation criteria apply: for example, treatment should reduce HbA1c by at least 11 mmol/mol (1.0%) and weight by at least 3% at 6 months to be continued

Consistency with injection timing is crucial for establishing a routine

For many individuals, GLP-1 therapy can finally make weight loss feel achievable after years of frustration with restrictive diets and short-term solutions

Yes, when performed correctly by a provider who understands Fitzpatrick classification and adjusts the protocol accordingly